Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sapheneia is a medical technology company specializing in image processing software designed to optimize diagnostic image quality while minimizing radiation exposure. The company's flagship Clarity platform uses advanced iterative reconstruction and AI-driven algorithms to reduce CT radiation doses by up to 80% without compromising diagnostic integrity. Sapheneia provides solutions for various imaging modalities, including CT, PET, and SPECT, serving hospitals and imaging centers globally. Their technology is vendor-agnostic, allowing it to be integrated with existing hardware from major manufacturers like GE, Siemens, and Philips. By enhancing legacy equipment with modern dose-reduction capabilities, Sapheneia helps healthcare providers improve patient safety and meet regulatory standards. The company operates internationally with a significant research and development presence in Sweden.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sapheneia.